Phase 3 Readout~month

Phase 3 Topline: An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Tr

Indication
Hepatitis C, Chronic; Hepatitis C; HEPATITIS C VIRUS CHRONIC INFECTION

Other upcoming events for AVIR

Phase 3 ReadoutPhase 3 Topline: Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvi

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Tr — AVIR Phase 3 Readout | BioSniper